ReviewPharmacoEconomics2001
Impact of allergic rhinitis treatment on quality of life.
Review in PharmacoEconomics, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 65 citations in OpenAlex.
- Different Development Forms of Local Allergic Rhinitis towards Birch.BioMed research international · 2020Trial
- Trial
- Long-term benefit after allergen immunotherapy to HDM in elderly patients with allergic rhinitis.Postepy dermatologii i alergologii · 2023Article
- Changes in ambient temperature increase hospital outpatient visits for allergic rhinitis in Xinxiang, China.BMC public health · 2021Article
- The Effect of Gelfoam Impregnated With Botulinum Toxin on Allergic Rhinitis.Iranian journal of otorhinolaryngology · 2019Article
- The effects of particulate matters on allergic rhinitis in Nanjing, China.Environmental science and pollution research international · 2019Article
- Insights on Allergic Rhinitis Management from a Northern Cyprus Perspective and Evaluation of the Impact of Pharmacist-Led Educational Intervention on Patients' Outcomes.Medicina (Kaunas, Lithuania) · 2018Article
- Prolonged effect of allergen sublingual immunotherapy to grass pollen.Human vaccines & immunotherapeutics · 2018Article
- Satisfaction and quality of life of allergic patients following sublingual five-grass pollen tablet immunotherapy in Spain.Drugs in context · 2017Article
- Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial.Clinical and translational allergy · 2017Article
- The relationship between hypertension and health-related quality of life: adjusted by chronic pain, chronic diseases, and life habits in the general middle-aged population in Japan.Environmental health and preventive medicine · 2016Article
- Reduced work/academic performance and quality of life in patients with allergic rhinitis and impact of allergen immunotherapy.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2016Article
- Septal injection in comparison with inferior turbinates injection of botulinum toxin A in patients with allergic rhinitis.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2013Article
- Clinical utility and patient adherence with ebastine for allergic rhinitis.Patient preference and adherence · 2010Article
- Epidemiology and burden of nasal congestion.International journal of general medicine · 2010Article
- Are the birch trees in Southern England a source of Betula pollen for North London?International journal of biometeorology · 2009Article
- Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairment.Clinical pharmacokinetics · 2007Article
- Levocetirizine: a review of its use in the management of allergic rhinitis and skin allergies.Drugs · 2006Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Allergic rhinitis is a chronic inflammatory disorder of the nasal passages. It affects approximately 20% of the population, is a significant health and economic burden, and severely impairs quality of life. Two main instruments, Medical Outcomes Study 36-Item Short Form health survey (SF-36) and Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) have been used to assess quality of life in patients with allergic rhinitis. Antihistamines, corticosteroids, anticholinergic agents, decongestants, cromoglycates, and immunotherapy are used to treat patients with allergic rhinitis. Of these, antihistamines and intranasal corticosteroids are the most efficacious and frequently utilised medications. Studies have demonstrated improvements in quality of life with both of these medications in patients with allergic rhinitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.